Compare CORT & FCFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | FCFS |
|---|---|---|
| Founded | 1998 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 9.7B |
| IPO Year | 2001 | 1996 |
| Metric | CORT | FCFS |
|---|---|---|
| Price | $95.41 | $196.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $96.50 | ★ $210.67 |
| AVG Volume (30 Days) | ★ 1.1M | 441.4K |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.78% |
| EPS Growth | N/A | ★ 29.49 |
| EPS | N/A | ★ 2.43 |
| Revenue | $761,407,000.00 | ★ $3,661,043,000.00 |
| Revenue This Year | $26.08 | $16.20 |
| Revenue Next Year | $26.98 | $8.35 |
| P/E Ratio | ★ N/A | $81.24 |
| Revenue Growth | ★ 12.79 | 8.04 |
| 52 Week Low | $28.66 | $119.21 |
| 52 Week High | $97.05 | $235.97 |
| Indicator | CORT | FCFS |
|---|---|---|
| Relative Strength Index (RSI) | 63.30 | 33.82 |
| Support Level | $76.41 | $180.26 |
| Resistance Level | N/A | $199.30 |
| Average True Range (ATR) | 4.17 | 9.15 |
| MACD | -0.36 | -1.94 |
| Stochastic Oscillator | 81.02 | 23.34 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
FirstCash Holdings Inc is an operator of pawn stores in the U.S., Latin America and the U.K. The company's primary line of business is the operation of retail pawn stores, also known as pawnshops. It also operates a retail POS payment solutions business. Its two business lines are organized into four reportable segments: The U.S. pawn segment consists of pawn operations in some of U.S. states and the District of Columbia; The Latin America pawn segment consists of pawn operations in Mexico, Guatemala, El Salvador and Colombia; The U.K. pawn segment consists of pawn operations in England, Scotland and Wales; and The retail POS payment solutions segment consists of the operations of American First Finance, LLC, which offers products in the U.S.